Rachmian, Noa
Medina, Sedi
Cherqui, Ulysse
Akiva, Hagay
Deitch, Daniel
Edilbi, Dunya
Croese, Tommaso http://orcid.org/0000-0002-3805-3429
Salame, Tomer Meir
Ramos, Javier Maria Peralta http://orcid.org/0000-0001-9730-9001
Cahalon, Liora
Krizhanovsky, Valery http://orcid.org/0000-0002-3977-5482
Schwartz, Michal http://orcid.org/0000-0003-4015-7507
Article History
Received: 8 May 2023
Accepted: 11 March 2024
First Online: 18 April 2024
Competing interests
: V.K. is a co-inventor of patents on senolytics and senolytic approaches and is a consultant for Sentaur Bio. None of these interests influenced the data presented in this manuscript. M.S. is a scientific co-founder of ImmunoBrain Checkpoint, which develops anti-PD-L1 to treat Alzheimerʼs disease. The other authors declare no competing interests.